Intriguingly, we also noticed a 2.6-fold down-regulation of FOXM1, an oncogenic transcription factor that forms a complex with MELK and is dependent on phosphorylation by MELK for its activity in glioma stem cells [34]. The gene discussed is MELK; the disease is central nervous system cancer.